

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.60026600 |
| 2 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 6.38860020 |
| 3 | actin nucleation (GO:0045010) | 6.08922555 |
| 4 | DNA deamination (GO:0045006) | 5.93497649 |
| 5 | cytidine metabolic process (GO:0046087) | 5.91419306 |
| 6 | cytidine catabolic process (GO:0006216) | 5.91419306 |
| 7 | cytidine deamination (GO:0009972) | 5.91419306 |
| 8 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.05708742 |
| 9 | cytolysis (GO:0019835) | 4.79077172 |
| 10 | kynurenine metabolic process (GO:0070189) | 4.54922521 |
| 11 | protein deneddylation (GO:0000338) | 4.41967447 |
| 12 | tryptophan catabolic process (GO:0006569) | 4.20786871 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 4.20786871 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 4.20786871 |
| 15 | metallo-sulfur cluster assembly (GO:0031163) | 3.97918286 |
| 16 | iron-sulfur cluster assembly (GO:0016226) | 3.97918286 |
| 17 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.81238783 |
| 18 | positive regulation of defense response to virus by host (GO:0002230) | 3.78168822 |
| 19 | tryptophan metabolic process (GO:0006568) | 3.63665680 |
| 20 | negative regulation by host of viral transcription (GO:0043922) | 3.62380169 |
| 21 | DNA dealkylation (GO:0035510) | 3.56037291 |
| 22 | DNA demethylation (GO:0080111) | 3.50943326 |
| 23 | negative regulation of stress fiber assembly (GO:0051497) | 3.47782558 |
| 24 | regulation of activation of Janus kinase activity (GO:0010533) | 3.45960135 |
| 25 | indolalkylamine metabolic process (GO:0006586) | 3.40667376 |
| 26 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.40087837 |
| 27 | inositol phosphate dephosphorylation (GO:0046855) | 3.40087837 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.34206829 |
| 29 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.34064393 |
| 30 | mannosylation (GO:0097502) | 3.33481248 |
| 31 | ubiquinone biosynthetic process (GO:0006744) | 3.27537878 |
| 32 | regulation of ruffle assembly (GO:1900027) | 3.27131217 |
| 33 | inositol phosphate catabolic process (GO:0071545) | 3.25099733 |
| 34 | platelet dense granule organization (GO:0060155) | 3.23205989 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.22310901 |
| 36 | negative T cell selection (GO:0043383) | 3.21279878 |
| 37 | cytochrome complex assembly (GO:0017004) | 3.20203022 |
| 38 | proteasome assembly (GO:0043248) | 3.19642623 |
| 39 | intestinal cholesterol absorption (GO:0030299) | 3.17816317 |
| 40 | regulation of defense response to virus by host (GO:0050691) | 3.14488279 |
| 41 | positive regulation of tolerance induction (GO:0002645) | 3.13349091 |
| 42 | negative regulation of viral genome replication (GO:0045071) | 3.11220468 |
| 43 | multicellular organism reproduction (GO:0032504) | 3.10127316 |
| 44 | gonadal mesoderm development (GO:0007506) | 3.04148803 |
| 45 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.03227533 |
| 46 | cellular response to interleukin-15 (GO:0071350) | 3.03218641 |
| 47 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.02486958 |
| 48 | positive regulation of prostaglandin secretion (GO:0032308) | 3.01826626 |
| 49 | ubiquinone metabolic process (GO:0006743) | 2.97624716 |
| 50 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.93267638 |
| 51 | protein complex biogenesis (GO:0070271) | 2.91589868 |
| 52 | protein K63-linked deubiquitination (GO:0070536) | 2.88379307 |
| 53 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.88370901 |
| 54 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.85897701 |
| 55 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.84179675 |
| 56 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.84179675 |
| 57 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.84179675 |
| 58 | fucose catabolic process (GO:0019317) | 2.83802845 |
| 59 | L-fucose metabolic process (GO:0042354) | 2.83802845 |
| 60 | L-fucose catabolic process (GO:0042355) | 2.83802845 |
| 61 | adaptation of signaling pathway (GO:0023058) | 2.83383996 |
| 62 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.80656258 |
| 63 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.79386836 |
| 64 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.79386836 |
| 65 | base-excision repair, AP site formation (GO:0006285) | 2.79147692 |
| 66 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.78518685 |
| 67 | quinone biosynthetic process (GO:1901663) | 2.78016661 |
| 68 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.77291121 |
| 69 | negative thymic T cell selection (GO:0045060) | 2.76208566 |
| 70 | positive thymic T cell selection (GO:0045059) | 2.75954560 |
| 71 | S-adenosylmethionine metabolic process (GO:0046500) | 2.75931670 |
| 72 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.74045510 |
| 73 | respiratory chain complex IV assembly (GO:0008535) | 2.73212190 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.72465761 |
| 75 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.71686458 |
| 76 | cullin deneddylation (GO:0010388) | 2.71406614 |
| 77 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.68364942 |
| 78 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.67866211 |
| 79 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.67866211 |
| 80 | positive regulation of cell killing (GO:0031343) | 2.67651201 |
| 81 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.67467186 |
| 82 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.66664658 |
| 83 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.65864108 |
| 84 | protein heterotetramerization (GO:0051290) | 2.65582223 |
| 85 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.64716840 |
| 86 | GPI anchor biosynthetic process (GO:0006506) | 2.64329653 |
| 87 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.64059364 |
| 88 | T cell migration (GO:0072678) | 2.64053509 |
| 89 | negative regulation of mast cell activation (GO:0033004) | 2.63709761 |
| 90 | negative regulation of T cell apoptotic process (GO:0070233) | 2.63117743 |
| 91 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.58844904 |
| 92 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.58641283 |
| 93 | piRNA metabolic process (GO:0034587) | 2.58561064 |
| 94 | GPI anchor metabolic process (GO:0006505) | 2.57945555 |
| 95 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.57438431 |
| 96 | deoxyribonucleotide catabolic process (GO:0009264) | 2.57206162 |
| 97 | male meiosis (GO:0007140) | 2.56814784 |
| 98 | deoxyribose phosphate catabolic process (GO:0046386) | 2.54636948 |
| 99 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.54152752 |
| 100 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.53198980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.57450886 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.54458632 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.42490632 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.34856229 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.17840448 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.87229932 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.75983301 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.58017075 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.52540734 |
| 10 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.48937992 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.40254154 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.39019196 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.09912851 |
| 14 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.07662274 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.04653383 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 1.99948325 |
| 17 | GATA3_26560356_Chip-Seq_TH2_Human | 1.99665502 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.98863459 |
| 19 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.97088926 |
| 20 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.90450235 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.83042775 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.80796596 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.78594323 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71220364 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.70234221 |
| 26 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.69105589 |
| 27 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.68365259 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.68055331 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.67549830 |
| 30 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.66079873 |
| 31 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.64617540 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.64201486 |
| 33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.58269565 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58150969 |
| 35 | AR_20517297_ChIP-Seq_VCAP_Human | 1.57623213 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.56546948 |
| 37 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.55856573 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55307372 |
| 39 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.55213709 |
| 40 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.53885246 |
| 41 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.53153343 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.50308302 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.50232122 |
| 44 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.47423009 |
| 45 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.47144909 |
| 46 | EWS_26573619_Chip-Seq_HEK293_Human | 1.45784883 |
| 47 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.44376670 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44143206 |
| 49 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.43927531 |
| 50 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.43484928 |
| 51 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.41770894 |
| 52 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.41498315 |
| 53 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.38877468 |
| 54 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.38877468 |
| 55 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.38416473 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.36387166 |
| 57 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.34774646 |
| 58 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.33956989 |
| 59 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.28413931 |
| 60 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.28413931 |
| 61 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.28302052 |
| 62 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.27146699 |
| 63 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.27146699 |
| 64 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.26633328 |
| 65 | GATA3_26560356_Chip-Seq_TH1_Human | 1.26428668 |
| 66 | NCOR_22424771_ChIP-Seq_293T_Human | 1.26165058 |
| 67 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.25739990 |
| 68 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.25543060 |
| 69 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21048374 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18224866 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.17335551 |
| 72 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.17100840 |
| 73 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.16868390 |
| 74 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.15477320 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14222242 |
| 76 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.13608971 |
| 77 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13327035 |
| 78 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.11277627 |
| 79 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10932756 |
| 80 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10105551 |
| 81 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09891802 |
| 82 | MYB_26560356_Chip-Seq_TH1_Human | 1.09284904 |
| 83 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.07949749 |
| 84 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07802248 |
| 85 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.06516531 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05189832 |
| 87 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04877219 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.03978685 |
| 89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03656202 |
| 90 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03175485 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03117836 |
| 92 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03033266 |
| 93 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.02872587 |
| 94 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00730554 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00532380 |
| 96 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.00510295 |
| 97 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99355806 |
| 98 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.98404064 |
| 99 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98308745 |
| 100 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97941953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.23766129 |
| 2 | MP0006072_abnormal_retinal_apoptosis | 3.63312420 |
| 3 | MP0002102_abnormal_ear_morphology | 3.37958921 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 2.79096326 |
| 5 | MP0002166_altered_tumor_susceptibility | 2.79088625 |
| 6 | MP0004147_increased_porphyrin_level | 2.73377322 |
| 7 | MP0009785_altered_susceptibility_to | 2.60629030 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.59356203 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.44981770 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.41344720 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.39694894 |
| 12 | MP0003866_abnormal_defecation | 2.34853386 |
| 13 | MP0002006_tumorigenesis | 2.22339686 |
| 14 | MP0003950_abnormal_plasma_membrane | 2.22105524 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.16345793 |
| 16 | MP0003045_fibrosis | 2.15465526 |
| 17 | MP0003878_abnormal_ear_physiology | 2.00915192 |
| 18 | MP0005377_hearing/vestibular/ear_phenot | 2.00915192 |
| 19 | MP0005387_immune_system_phenotype | 1.98870143 |
| 20 | MP0001790_abnormal_immune_system | 1.98870143 |
| 21 | MP0003646_muscle_fatigue | 1.95628328 |
| 22 | MP0002876_abnormal_thyroid_physiology | 1.87592817 |
| 23 | MP0005253_abnormal_eye_physiology | 1.76942094 |
| 24 | MP0001800_abnormal_humoral_immune | 1.71079044 |
| 25 | MP0005551_abnormal_eye_electrophysiolog | 1.68685817 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 1.65108873 |
| 27 | MP0006292_abnormal_olfactory_placode | 1.59481688 |
| 28 | MP0000685_abnormal_immune_system | 1.55160271 |
| 29 | MP0008877_abnormal_DNA_methylation | 1.54141997 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 1.50901259 |
| 31 | MP0005025_abnormal_response_to | 1.48071578 |
| 32 | MP0005645_abnormal_hypothalamus_physiol | 1.47491832 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.46324136 |
| 34 | MP0002723_abnormal_immune_serum | 1.45262057 |
| 35 | MP0001819_abnormal_immune_cell | 1.42850068 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.36161473 |
| 37 | MP0002095_abnormal_skin_pigmentation | 1.28967270 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.28413886 |
| 39 | MP0005365_abnormal_bile_salt | 1.26206567 |
| 40 | MP0003252_abnormal_bile_duct | 1.26020310 |
| 41 | MP0001905_abnormal_dopamine_level | 1.25609817 |
| 42 | MP0005410_abnormal_fertilization | 1.25211088 |
| 43 | MP0005360_urolithiasis | 1.24169502 |
| 44 | MP0008058_abnormal_DNA_repair | 1.23790155 |
| 45 | MP0008057_abnormal_DNA_replication | 1.23687220 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.20398965 |
| 47 | MP0005075_abnormal_melanosome_morpholog | 1.20108087 |
| 48 | MP0000372_irregular_coat_pigmentation | 1.19626213 |
| 49 | MP0003868_abnormal_feces_composition | 1.18197300 |
| 50 | MP0003195_calcinosis | 1.16290368 |
| 51 | MP0004134_abnormal_chest_morphology | 1.15937962 |
| 52 | MP0000427_abnormal_hair_cycle | 1.13408637 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.12796482 |
| 54 | MP0005083_abnormal_biliary_tract | 1.08823178 |
| 55 | MP0003283_abnormal_digestive_organ | 1.07162722 |
| 56 | MP0001529_abnormal_vocalization | 1.04791881 |
| 57 | MP0005389_reproductive_system_phenotype | 1.04060641 |
| 58 | MP0000716_abnormal_immune_system | 1.01037978 |
| 59 | MP0008872_abnormal_physiological_respon | 0.99234201 |
| 60 | MP0003786_premature_aging | 0.97514951 |
| 61 | MP0002653_abnormal_ependyma_morphology | 0.96648089 |
| 62 | MP0003724_increased_susceptibility_to | 0.96504111 |
| 63 | MP0005220_abnormal_exocrine_pancreas | 0.96176762 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 0.94886072 |
| 65 | MP0003448_altered_tumor_morphology | 0.94314066 |
| 66 | MP0002160_abnormal_reproductive_system | 0.94196052 |
| 67 | MP0002234_abnormal_pharynx_morphology | 0.93197599 |
| 68 | MP0010329_abnormal_lipoprotein_level | 0.93160318 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 0.92331183 |
| 70 | MP0005266_abnormal_metabolism | 0.90924151 |
| 71 | MP0000689_abnormal_spleen_morphology | 0.90460087 |
| 72 | MP0002736_abnormal_nociception_after | 0.89534220 |
| 73 | MP0001119_abnormal_female_reproductive | 0.86917629 |
| 74 | MP0004885_abnormal_endolymph | 0.86556408 |
| 75 | MP0001485_abnormal_pinna_reflex | 0.85798573 |
| 76 | MP0002398_abnormal_bone_marrow | 0.82823750 |
| 77 | MP0001919_abnormal_reproductive_system | 0.82236945 |
| 78 | MP0002722_abnormal_immune_system | 0.80908061 |
| 79 | MP0001845_abnormal_inflammatory_respons | 0.80010613 |
| 80 | MP0009697_abnormal_copulation | 0.79185555 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 0.78374561 |
| 82 | MP0006276_abnormal_autonomic_nervous | 0.77681900 |
| 83 | MP0002419_abnormal_innate_immunity | 0.77075244 |
| 84 | MP0002009_preneoplasia | 0.75777453 |
| 85 | MP0001968_abnormal_touch/_nociception | 0.74772777 |
| 86 | MP0002693_abnormal_pancreas_physiology | 0.74527105 |
| 87 | MP0002405_respiratory_system_inflammati | 0.73259027 |
| 88 | MP0010386_abnormal_urinary_bladder | 0.73220648 |
| 89 | MP0010368_abnormal_lymphatic_system | 0.72609048 |
| 90 | MP0006054_spinal_hemorrhage | 0.71350065 |
| 91 | MP0009333_abnormal_splenocyte_physiolog | 0.71168870 |
| 92 | MP0009763_increased_sensitivity_to | 0.70771745 |
| 93 | MP0000749_muscle_degeneration | 0.70121769 |
| 94 | MP0003638_abnormal_response/metabolism_ | 0.69682836 |
| 95 | MP0000703_abnormal_thymus_morphology | 0.68796870 |
| 96 | MP0002429_abnormal_blood_cell | 0.68446780 |
| 97 | MP0001502_abnormal_circadian_rhythm | 0.67362694 |
| 98 | MP0006082_CNS_inflammation | 0.66634385 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.66589645 |
| 100 | MP0001765_abnormal_ion_homeostasis | 0.66332299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prostate neoplasm (HP:0100787) | 4.93163729 |
| 2 | Aplastic anemia (HP:0001915) | 3.99626495 |
| 3 | T lymphocytopenia (HP:0005403) | 3.88068991 |
| 4 | Abnormality of the prostate (HP:0008775) | 3.73953723 |
| 5 | Abnormality of T cell number (HP:0011839) | 3.65458915 |
| 6 | IgG deficiency (HP:0004315) | 3.65297045 |
| 7 | Hepatocellular necrosis (HP:0001404) | 3.56479116 |
| 8 | Congenital stationary night blindness (HP:0007642) | 3.55213389 |
| 9 | Amyotrophic lateral sclerosis (HP:0007354) | 3.50543739 |
| 10 | Hypoproteinemia (HP:0003075) | 3.41091120 |
| 11 | Hepatic necrosis (HP:0002605) | 3.37051431 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.16978971 |
| 13 | Renal cortical cysts (HP:0000803) | 3.04393425 |
| 14 | Mitochondrial inheritance (HP:0001427) | 3.02852051 |
| 15 | True hermaphroditism (HP:0010459) | 2.94075878 |
| 16 | Pancreatic fibrosis (HP:0100732) | 2.93490386 |
| 17 | Abnormality of midbrain morphology (HP:0002418) | 2.91404010 |
| 18 | Molar tooth sign on MRI (HP:0002419) | 2.91404010 |
| 19 | Abnormality of the renal cortex (HP:0011035) | 2.85512347 |
| 20 | Pancreatic cysts (HP:0001737) | 2.85306895 |
| 21 | 3-Methylglutaconic aciduria (HP:0003535) | 2.73847729 |
| 22 | Medial flaring of the eyebrow (HP:0010747) | 2.71206595 |
| 23 | Increased intramyocellular lipid droplets (HP:0012240) | 2.70884532 |
| 24 | Increased serum lactate (HP:0002151) | 2.69056775 |
| 25 | Increased CSF lactate (HP:0002490) | 2.66696831 |
| 26 | Nephronophthisis (HP:0000090) | 2.66673437 |
| 27 | Recurrent bronchitis (HP:0002837) | 2.65657450 |
| 28 | Generalized aminoaciduria (HP:0002909) | 2.63115464 |
| 29 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.60488434 |
| 30 | Abnormality of alanine metabolism (HP:0010916) | 2.60488434 |
| 31 | Hyperalaninemia (HP:0003348) | 2.60488434 |
| 32 | Abolished electroretinogram (ERG) (HP:0000550) | 2.60044057 |
| 33 | IgM deficiency (HP:0002850) | 2.54033916 |
| 34 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.51431739 |
| 35 | Renal Fanconi syndrome (HP:0001994) | 2.48350938 |
| 36 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.47600596 |
| 37 | Absent/shortened dynein arms (HP:0200106) | 2.47600596 |
| 38 | Severe combined immunodeficiency (HP:0004430) | 2.46762630 |
| 39 | Abnormal albumin level (HP:0012116) | 2.43705377 |
| 40 | Hypoalbuminemia (HP:0003073) | 2.43705377 |
| 41 | Autoimmune hemolytic anemia (HP:0001890) | 2.43603988 |
| 42 | Abnormality of T cells (HP:0002843) | 2.42186089 |
| 43 | Facial diplegia (HP:0001349) | 2.41171738 |
| 44 | Chronic diarrhea (HP:0002028) | 2.38685831 |
| 45 | Thyroiditis (HP:0100646) | 2.34753116 |
| 46 | Increased IgM level (HP:0003496) | 2.33887280 |
| 47 | Colon cancer (HP:0003003) | 2.30851762 |
| 48 | Abnormality of the renal medulla (HP:0100957) | 2.28322354 |
| 49 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.27198172 |
| 50 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.26522926 |
| 51 | Supernumerary spleens (HP:0009799) | 2.25748385 |
| 52 | Congenital primary aphakia (HP:0007707) | 2.25660345 |
| 53 | Chronic hepatic failure (HP:0100626) | 2.25626315 |
| 54 | Agammaglobulinemia (HP:0004432) | 2.24802493 |
| 55 | Acute hepatic failure (HP:0006554) | 2.24236025 |
| 56 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.23770029 |
| 57 | Abnormality of male internal genitalia (HP:0000022) | 2.19979758 |
| 58 | Polydipsia (HP:0001959) | 2.19196910 |
| 59 | Abnormal drinking behavior (HP:0030082) | 2.19196910 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.16179488 |
| 61 | Bronchitis (HP:0012387) | 2.15414976 |
| 62 | Anhidrosis (HP:0000970) | 2.13884952 |
| 63 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.13875638 |
| 64 | Gait imbalance (HP:0002141) | 2.13833977 |
| 65 | Hypoplasia of the uterus (HP:0000013) | 2.13269974 |
| 66 | Acute necrotizing encephalopathy (HP:0006965) | 2.10551085 |
| 67 | Cellular immunodeficiency (HP:0005374) | 2.08190462 |
| 68 | Pancytopenia (HP:0001876) | 2.06102772 |
| 69 | Premature graying of hair (HP:0002216) | 1.96678826 |
| 70 | Nephrogenic diabetes insipidus (HP:0009806) | 1.96649512 |
| 71 | Abnormal spermatogenesis (HP:0008669) | 1.95538662 |
| 72 | Increased muscle lipid content (HP:0009058) | 1.95273462 |
| 73 | Stomach cancer (HP:0012126) | 1.95128803 |
| 74 | Abnormality of B cell number (HP:0010975) | 1.94291197 |
| 75 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93994299 |
| 76 | Tongue fasciculations (HP:0001308) | 1.91478502 |
| 77 | Encephalitis (HP:0002383) | 1.91001542 |
| 78 | Tubulointerstitial nephritis (HP:0001970) | 1.90021177 |
| 79 | Abnormal protein glycosylation (HP:0012346) | 1.89277847 |
| 80 | Abnormal glycosylation (HP:0012345) | 1.89277847 |
| 81 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.89277847 |
| 82 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.89277847 |
| 83 | Oral leukoplakia (HP:0002745) | 1.89195776 |
| 84 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.86726270 |
| 85 | Chronic sinusitis (HP:0011109) | 1.85077233 |
| 86 | Abnormality of urine glucose concentration (HP:0011016) | 1.85056950 |
| 87 | Glycosuria (HP:0003076) | 1.85056950 |
| 88 | Attenuation of retinal blood vessels (HP:0007843) | 1.84653479 |
| 89 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.83761859 |
| 90 | Lactic acidosis (HP:0003128) | 1.82625584 |
| 91 | Tubular atrophy (HP:0000092) | 1.81627975 |
| 92 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.81057066 |
| 93 | Genital tract atresia (HP:0001827) | 1.80464185 |
| 94 | Nemaline bodies (HP:0003798) | 1.79205720 |
| 95 | Combined immunodeficiency (HP:0005387) | 1.77131850 |
| 96 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.76987582 |
| 97 | Type I transferrin isoform profile (HP:0003642) | 1.76184666 |
| 98 | Glucose intolerance (HP:0000833) | 1.75929157 |
| 99 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.74570951 |
| 100 | Conical tooth (HP:0000698) | 1.74134935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 8.17938718 |
| 2 | KDR | 4.96101003 |
| 3 | GRK1 | 3.10203363 |
| 4 | ZAK | 3.02887550 |
| 5 | VRK2 | 2.56498169 |
| 6 | FRK | 2.55697593 |
| 7 | BCKDK | 2.48694550 |
| 8 | TLK1 | 2.27870019 |
| 9 | MUSK | 2.10401472 |
| 10 | TESK1 | 2.06638813 |
| 11 | TIE1 | 1.97140330 |
| 12 | STK16 | 1.94927597 |
| 13 | ITK | 1.91230753 |
| 14 | NUAK1 | 1.80152831 |
| 15 | TAOK3 | 1.79540530 |
| 16 | MAPKAPK3 | 1.79104717 |
| 17 | VRK1 | 1.74054057 |
| 18 | LIMK1 | 1.73745033 |
| 19 | TEC | 1.55197517 |
| 20 | TXK | 1.52970575 |
| 21 | EIF2AK3 | 1.52635893 |
| 22 | EIF2AK1 | 1.48476252 |
| 23 | SCYL2 | 1.47855658 |
| 24 | MAP4K1 | 1.46980973 |
| 25 | ACVR1B | 1.44898073 |
| 26 | PIK3CA | 1.33162588 |
| 27 | MAP3K12 | 1.30557421 |
| 28 | WNK3 | 1.16180405 |
| 29 | ADRBK2 | 1.13762275 |
| 30 | SYK | 1.11457384 |
| 31 | TNIK | 1.03201441 |
| 32 | BMPR1B | 1.00003662 |
| 33 | BRSK2 | 0.97948511 |
| 34 | DAPK1 | 0.95999333 |
| 35 | ERBB3 | 0.93683571 |
| 36 | MAP4K2 | 0.88975278 |
| 37 | TRPM7 | 0.84833614 |
| 38 | TNK2 | 0.84274498 |
| 39 | CAMKK2 | 0.79801955 |
| 40 | OBSCN | 0.76120110 |
| 41 | MYLK | 0.75992882 |
| 42 | IKBKE | 0.70935684 |
| 43 | AKT3 | 0.69509066 |
| 44 | LCK | 0.68904442 |
| 45 | PIK3CG | 0.68903780 |
| 46 | TBK1 | 0.67337762 |
| 47 | CSNK1A1L | 0.63683328 |
| 48 | CSNK1G3 | 0.63562425 |
| 49 | PRKD3 | 0.61159701 |
| 50 | PRKCQ | 0.60161805 |
| 51 | MAPK13 | 0.59230773 |
| 52 | BLK | 0.59218251 |
| 53 | BMPR2 | 0.58740619 |
| 54 | GRK7 | 0.57231173 |
| 55 | ROCK1 | 0.56598174 |
| 56 | BTK | 0.56402524 |
| 57 | INSRR | 0.55746481 |
| 58 | CAMK1D | 0.54525521 |
| 59 | CSNK1G1 | 0.54135948 |
| 60 | MST4 | 0.52892682 |
| 61 | IKBKB | 0.52249016 |
| 62 | ADRBK1 | 0.50794955 |
| 63 | WNK4 | 0.49185246 |
| 64 | LYN | 0.48745400 |
| 65 | MAPKAPK5 | 0.47503679 |
| 66 | GRK5 | 0.46198318 |
| 67 | FES | 0.44523674 |
| 68 | MAPKAPK2 | 0.44055403 |
| 69 | PTK2B | 0.43871263 |
| 70 | PLK4 | 0.43476030 |
| 71 | BUB1 | 0.43209583 |
| 72 | RPS6KA5 | 0.42845178 |
| 73 | TGFBR2 | 0.41586256 |
| 74 | IGF1R | 0.41512462 |
| 75 | MAP3K11 | 0.41494686 |
| 76 | CSK | 0.40524855 |
| 77 | PDK2 | 0.40509728 |
| 78 | GRK6 | 0.40216832 |
| 79 | EIF2AK2 | 0.39386846 |
| 80 | ZAP70 | 0.36413967 |
| 81 | AURKA | 0.35021652 |
| 82 | CHEK2 | 0.33829726 |
| 83 | PLK2 | 0.33755660 |
| 84 | HCK | 0.33531498 |
| 85 | CSNK1G2 | 0.31134094 |
| 86 | NEK1 | 0.30776362 |
| 87 | PRKACA | 0.29928213 |
| 88 | PLK3 | 0.29403504 |
| 89 | CHUK | 0.29095265 |
| 90 | ATR | 0.28954520 |
| 91 | AURKB | 0.28806448 |
| 92 | CSNK1A1 | 0.28163226 |
| 93 | INSR | 0.26880397 |
| 94 | TAF1 | 0.26142669 |
| 95 | PRKCA | 0.25147218 |
| 96 | PRKAA2 | 0.24439392 |
| 97 | TGFBR1 | 0.24092193 |
| 98 | FYN | 0.23575768 |
| 99 | MKNK2 | 0.22924457 |
| 100 | MAP3K14 | 0.21849199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.55823197 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.07448896 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 4.04740863 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.59352205 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.50586184 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.35265416 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.33214080 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.32589197 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.30876329 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 2.21707908 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.11002355 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.00517146 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.99624111 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.86961333 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.81681672 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.66525750 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.64090832 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 1.63491364 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57029718 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53738329 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.51472073 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.46902700 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42870801 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.40207952 |
| 25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.36612285 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.26497286 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24329318 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.18216899 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17700665 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17308950 |
| 31 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.16395823 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09122840 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07936640 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07501974 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.05878071 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.05640998 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00664936 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00336370 |
| 39 | RNA degradation_Homo sapiens_hsa03018 | 1.00012069 |
| 40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.99620668 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98045654 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96783111 |
| 43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94969465 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.94747606 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93337471 |
| 46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.93061390 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92276684 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91104112 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.90886417 |
| 50 | Alzheimers disease_Homo sapiens_hsa05010 | 0.89467063 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.89359966 |
| 52 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.89140367 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.87870188 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 0.87280979 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84685441 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83753128 |
| 57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.82185523 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81496816 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81302878 |
| 60 | Purine metabolism_Homo sapiens_hsa00230 | 0.81282418 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.80788845 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.80635655 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.80262786 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77751105 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77603002 |
| 66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.75990868 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68010845 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67637823 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67447162 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67344819 |
| 71 | Homologous recombination_Homo sapiens_hsa03440 | 0.62974629 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61003657 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58667270 |
| 74 | Basal transcription factors_Homo sapiens_hsa03022 | 0.56155467 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54182088 |
| 76 | Measles_Homo sapiens_hsa05162 | 0.50711700 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50282569 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48377258 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47573602 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47284222 |
| 81 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46736907 |
| 82 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43830109 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42834011 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40932166 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40503382 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.39275434 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.39256034 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38306036 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37353818 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36588287 |
| 91 | Mismatch repair_Homo sapiens_hsa03430 | 0.33666359 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.32668992 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32153169 |
| 94 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.31676444 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.31144792 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.30494669 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29500732 |
| 98 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.25884680 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.24138263 |
| 100 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.23029237 |

